NCT00609947

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.

A Clinical Evaluation of the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 241 (actual)
• Sponsor: Medtronic Vascular · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to verify the safety and efficacy of the Endeavor Zotarolimus-Eluting Coronary Stent System for improving coronary luminal diameter in patients with ischemic heart disease due to de novo lesions of length ≤27 mm in native coronary arteries with reference vessels ≥ 2.25 mm to ≤ 2.75 mm.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Endeavor Zotarolimus-Eluting Coronary Stent

Timeline

• Start date: 2008-01-01
• Primary completion: 2012-03-01
• Completion: 2013-09-01
• First posted: 2008-02-07
• Last updated: 2015-02-09
• Results posted: 2015-01-26

Locations

1 site across 1 country: United States